Close Menu

NEW YORK (GenomeWeb) – Exact Sciences announced today plans for an underwritten public offering of $650 million worth of 0.3750 percent convertible senior notes due 2027. 

The company has also granted the underwriter a 30-day option to purchase up to an additional $97.5 million of the notes to cover any over-allotments. BofA Merrill Lynch is acting as sole book-running manager for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.

He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.

Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.

In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.